use
vaccin
result
remark
improv
global
health
save
sever
live
reduc
treatment
cost
rais
qualiti
anim
human
live
current
tradit
vaccin
came
empir
either
vagu
complet
knowledg
modul
immun
system
even
face
potenti
vaccin
design
advanc
immunerel
concern
seen
specif
vulner
popul
case
emergingreemerg
infecti
diseas
pathogen
complex
lifecycl
antigen
variabl
need
person
vaccin
concern
vaccin
immunolog
safeti
specif
vaccin
likelihood
trigger
nonantigenspecif
respons
may
caus
autoimmun
vaccin
allergi
rais
concern
driven
immunologist
toward
research
better
approach
vaccin
design
consid
challeng
current
immunoinformat
pave
way
better
understand
infecti
diseas
pathogenesi
diagnosi
immun
system
respons
comput
vaccinolog
import
immunoinformat
studi
infecti
diseas
divers
term
comput
approach
use
unit
common
qualiti
relat
hostpathogen
relationship
bioinformat
method
also
use
assign
function
uncharacter
gene
target
candid
vaccin
design
better
approach
toward
inclus
women
pregnant
vaccin
trial
program
essenc
review
give
insight
need
focu
novel
comput
experiment
computationdriven
experiment
approach
studi
hostpathogen
interact
thu
make
case
use
vaccin
develop
vaccin
undeni
help
promot
healthi
global
popul
sever
save
live
reduc
healthcar
cost
rais
man
qualiti
life
greatli
reduc
diseas
burden
disabl
death
howev
newli
emerg
reemerg
infecti
diseas
erid
infecti
agent
complex
lifecycl
antigen
variabl
need
person
vaccin
present
addit
challeng
vaccin
develop
mani
pathogen
especi
emerg
antigen
variabl
genom
known
immun
correl
protect
remain
unclear
reason
vaccin
develop
erid
multilifecycl
pathogen
diseas
tall
order
serendipit
discoveri
immunolog
coupl
knowledg
bioinformat
tool
epitop
predict
result
emerg
new
pattern
vaccin
design
art
scienc
effici
comprehens
inform
extract
analysi
data
deposit
relev
databas
increasingli
essenti
research
relat
immunolog
even
capac
effici
inform
extract
challeng
applic
bioinformat
immunolog
includ
structur
andor
function
analysi
immun
process
analys
concern
immun
interact
specif
fortun
although
research
immunolog
experiment
costli
intens
coloss
amount
data
usual
gener
data
analyz
high
precis
speed
use
bioinformat
tool
instanc
genom
sequenc
well
vitro
tcell
confirm
done
month
oppos
year
use
convent
vaccin
design
also
comput
immunolog
method
drastic
reduc
time
labor
need
epitop
screen
comput
immunolog
techniqu
possibl
discov
vaccin
candid
epitop
simpli
scan
protein
sequenc
pathogen
interest
mani
protein
yet
isol
least
clone
pathogen
specif
uniqu
present
readi
candid
vaccin
construct
review
describ
need
use
immunoinformaticsbas
techniqu
unveil
vital
determin
immun
made
avail
genom
sequenc
databas
design
vaccin
also
review
give
insight
need
focu
novel
comput
experiment
computationdriven
experiment
approach
studi
hostpathogen
interact
thu
make
case
use
vaccin
develop
review
show
need
new
approach
effect
drug
vaccin
design
combat
antigen
variabl
pathogen
process
gener
vaccineinduc
immun
somewhat
challeng
immunolog
current
convent
vaccin
came
empir
vagu
knowledg
vaccin
immun
system
activ
lot
research
gear
toward
understand
challeng
complex
requir
differ
dimens
approach
approach
must
accommod
mani
factor
affect
vaccin
develop
like
pathogen
antigen
variabl
emerg
infecti
diseas
human
genet
variat
goal
immunoinformat
figur
activ
immun
system
involv
among
mani
process
induct
immun
memori
strength
induct
determin
efficaci
vaccin
henc
vaccin
efficaci
long
run
influenc
determin
immunolog
memori
stimul
persist
antibodi
kind
type
immun
memori
cell
induc
primari
vaccinemedi
immunolog
effector
tabl
mainli
antibodi
b
lymphocyt
cell
sometim
cell
antibodi
bind
specif
particular
kind
toxin
pathogen
vaccin
antigen
evok
humor
well
cellmedi
immun
respons
vaccin
mediat
immun
respons
system
b
cell
respons
said
effect
although
b
cell
regard
primari
vaccin
immun
effector
cell
induc
immun
memori
cell
highaffin
antibodi
studi
revers
vaccinolog
immunom
also
prove
cell
prime
immun
effector
follow
discoveri
novel
vaccin
target
epimatrix
chang
immun
target
led
success
advanc
vaccin
design
even
face
potenti
vaccin
design
advanc
immunerel
question
focus
specif
vulner
popul
young
elderli
immunocompromis
concern
propel
better
understand
efficaci
current
vaccin
vulner
popul
also
pave
way
applic
new
approach
put
consider
differ
popul
better
target
gener
optimum
immun
induct
except
type
ii
tcellindepend
antigen
ie
polysaccharid
antigen
antigen
could
provok
b
lymphocyt
well
lymphocyt
respons
stimul
germin
center
caus
antigenspecif
highli
effici
bcell
multipl
eventu
differenti
antibodyform
plasma
cell
memori
b
cell
exist
protein
dna
antigen
induc
immunolog
memori
b
cell
unlik
type
ii
tcellindepend
antigen
ie
polysaccharid
antigen
polysaccharid
antigen
gener
memori
b
cell
induc
longlast
humor
immun
even
recal
respons
lack
vaccin
efficaci
may
short
term
b
cell
activ
tradit
approach
develop
vaccin
infecti
diseas
threat
shift
includ
vaccin
design
techniqu
like
clone
express
major
surfac
antigen
although
frequent
result
formul
vaccin
poor
immunogen
requir
strong
adjuvant
approach
particularli
like
less
specif
pathogen
complex
lifecycl
eg
parasit
high
mutabl
eg
rna
virus
pathogen
depend
one
rout
virul
pathogenesi
human
thu
alter
process
increas
specif
vaccin
aim
effect
seen
current
convent
vaccin
vaccin
sever
neglect
tropic
diseas
variou
stage
develop
thank
mega
drug
compani
continu
demonstr
willing
invest
money
research
develop
regard
diseas
plagu
develop
nation
pertin
invest
research
interest
vaccin
specif
pathogen
antigen
total
comput
vaccinolog
may
appli
screen
genom
possibl
vaccin
target
tool
mani
protein
virul
interest
sequenc
essenti
gene
interest
model
potenti
vaccin
candid
specif
pathogen
immunoinformat
way
forward
identif
vaccin
candid
tropic
erid
pathogen
vari
antigen
individu
therapi
immunolog
studi
produc
data
coloss
quantiti
also
proteom
genom
project
extens
screen
pathogen
andor
pathogenhost
interact
becom
increasingli
necessari
store
manag
analyz
data
henc
birth
immunoinformat
immunoinformat
deal
comput
techniqu
resourc
use
studi
immun
function
statist
comput
mathemat
biolog
knowledg
tool
appli
immunoinformat
order
accur
specif
store
analyz
data
concern
immun
system
function
handl
evid
divers
immunoinformat
use
tool
cut
across
sever
aspect
bioinformat
creation
manag
databas
use
definit
structur
function
signatur
format
applic
predict
tool
strategi
synerg
toward
better
understand
immun
system
man
anim
fight
less
predict
pathogenesi
complex
natur
vertebr
immun
system
variabl
natur
pathogen
environment
antigen
coupl
multiregulatori
pathway
show
coloss
quantiti
data
need
unveil
human
immun
system
work
convent
much
achiev
base
complex
immun
system
virul
antigen
applic
comput
vaccinolog
research
vaccin
design
made
easier
accur
specif
appli
immunoinformat
diseas
studi
tabl
requir
knowledg
diseas
pathogenesi
immun
system
dynam
comput
vaccinolog
painstak
search
databas
sequenc
comparison
structur
model
well
motif
analysi
method
go
long
way
analyz
pathogenesi
diseas
identif
vaccin
candid
order
help
understand
complex
pathogenrel
process
comput
model
develop
viral
bacteri
parasit
fungal
pathogen
bioinformat
tool
tabl
use
identifi
possibl
epitop
vaccin
formul
tool
screen
protein
sequenc
identifi
aggreg
mhc
bind
supertyp
motif
possibl
use
epitopebas
vaccin
develop
use
among
human
popul
genet
variabl
sever
databas
tabl
provid
wide
rang
inform
form
immunolog
studi
gener
data
studi
organ
store
databas
tabl
provid
mean
develop
advanc
immunotarget
therapi
immunolog
research
tour
databas
actual
stimul
interest
vaccinolog
emerg
resurg
disord
attribut
pathogen
includ
cancer
emerg
infect
ei
includ
infect
entir
new
popul
may
exist
popul
gain
rapid
continu
spread
andor
wide
geograph
rang
reemerg
resurg
infect
repres
infect
previous
histor
relev
quickli
becom
relev
either
increas
incid
increas
geograph
andor
human
host
rang
emerg
infect
repres
infect
origin
observ
man
sever
factor
human
behavior
chang
environment
chang
hostintermedi
factor
animalhuman
switch
microbi
genet
chang
affect
infecti
diseas
emerg
spread
factor
interact
promot
evolut
pathogen
new
ecosystem
infect
spread
thrive
new
host
overal
consequ
continu
epimatrix
insilico
product
epivax
develop
predict
identifi
immunogen
therapeut
protein
epitop
also
use
redesign
protein
design
tcell
vaccin
appli
compar
string
differ
strain
pathogen
pathogen
identif
configur
conservatrix
allow
amino
acid
replac
unusu
posit
highli
conserv
tcell
epitop
variabl
genom
virus
amen
algorithm
clustim
potenti
tcell
epitop
usual
aggreg
specif
immunogen
consensu
sequenc
ic
region
cluster
amino
acid
bind
motif
instead
randomli
distribut
throughout
protein
sequenc
combin
epimatrix
clustim
algorithm
may
use
identifi
peptid
epimatrix
immunogen
cluster
score
peptid
usual
immunogen
tend
make
promis
vaccin
candid
blastim
use
blastim
program
one
may
also
choos
automat
blast
put
epitop
human
sequenc
databas
genbank
blast
screen
epitop
possibl
autoimmun
cross
reactiv
question
locat
epitop
safe
use
develop
human
anim
vaccin
blastim
also
blast
sequenc
pdb
swissprot
pir
prf
nonredund
genbank
cd
translat
vaccin
cad
algorithm
evalu
junction
epitop
possibl
immunogen
insert
spacer
breaker
design
stringofbead
construct
infecti
diseas
emerg
reemerg
epidem
public
health
challeng
emerg
infect
multiantibioticresist
strain
pathogen
bacteria
usual
surg
one
geograph
locat
spread
place
due
immigr
peopl
emerg
infect
origin
specif
popul
spread
new
popul
becom
select
advantag
lead
emerg
new
strain
pathogen
also
could
microbi
traffic
case
infecti
agent
transfer
anim
human
spread
isol
group
new
popul
sever
factor
includ
ecolog
known
associ
infecti
diseas
outbreak
factor
bring
man
close
contact
natur
diseas
reservoirhost
increas
world
popul
poor
infect
control
emerg
infect
increas
microbi
popul
sure
human
growth
popul
increas
spread
infect
across
popul
inform
provid
tabl
list
remerg
infect
current
emerg
diseas
put
forward
annual
review
review
note
infect
well
control
caus
diseas
outbreak
bioterror
similar
occurr
requir
urgent
public
health
attent
dearth
efficaci
medicin
vaccin
compel
demand
continu
well
acceler
research
develop
area
advanc
genom
proteom
immunom
vaccinom
nanotechnolog
continu
exploit
diagnost
therapeut
ration
drug
vaccin
develop
advanc
also
serv
control
aforement
emerg
knowledg
emerg
pathogen
genom
protein
makeup
pathogenimmun
system
interact
research
possibl
therapeut
go
long
way
direct
optimum
path
contain
infect
spread
control
potenti
reemerg
emerg
differ
popul
approach
direct
computerbas
structur
determin
proteinprotein
interact
predict
bioinformat
tool
exist
use
modernday
develop
drug
biolog
vaccin
develop
sped
advanc
knowledg
immun
system
man
research
tradit
target
vaccin
adapt
immun
respons
less
specif
fastact
innat
immun
respons
clear
evid
advanc
understand
intercours
innat
adapt
immun
increas
reason
opportun
effect
vaccin
adjuv
open
step
forward
solv
critic
world
health
challeng
per
popul
follow
convent
approach
vaccin
design
much
achiev
knowledg
immunoinformat
appli
popul
safeti
diseas
control
achiev
pathogen
genom
sequenc
lead
optimum
new
vaccin
design
develop
novel
vaccin
infect
antigen
variabl
import
mechan
pathogen
use
evad
host
immun
surfac
protein
pathogen
normal
variabl
assist
escap
recognit
immun
system
success
infecti
agent
present
host
immun
system
inform
differ
virul
pathogen
organ
organ
system
escap
destruct
immun
system
host
instanc
toxoplasma
invad
appropri
host
cell
therebi
circumv
phagocytosi
spread
within
host
establish
infect
vertebr
endow
immun
system
robust
enough
effici
effect
surmount
nonselfattack
yet
host
immun
system
elabor
better
organ
evas
immun
effector
cell
antigen
variat
refer
pathogen
abil
modifi
surfac
protein
circumv
host
immunolog
attack
involv
sever
mechan
includ
vari
surfac
protein
phase
shift
drift
surfac
protein
antigen
andor
form
alter
antigen
protein
antigen
variat
play
signific
role
pathogen
microorgan
evas
host
immun
respons
establish
reinfect
pathogen
alter
surfac
antigen
evad
host
adapt
immun
reestablish
infect
immun
system
may
battl
gener
new
immunoglobulin
new
antigen
certain
bacteria
like
neisseria
gonorrhea
neisseria
meningitid
mycoplasma
speci
genu
streptococcu
show
antigen
divers
eukaryot
pathogen
antigen
variat
shown
trypanosoma
brucei
plasmodium
falciparum
anoth
vital
caus
antigen
variat
bacteria
horizont
gene
transfer
import
point
mutat
plasmid
acquisit
transduct
via
bacteriophag
virul
gene
normal
acquir
nonvirul
organ
via
rout
occur
new
bacteria
may
quickli
get
establish
caus
fresh
epidem
outbreak
speci
genu
neisseria
champion
rapid
chang
surfac
antigen
amongst
bacteri
pathogen
pathogen
form
exhibit
amount
phenotyp
variabl
found
commens
speci
pathogen
form
implic
std
mening
employ
amaz
varieti
antigen
variabl
mechan
recombin
pilin
gene
similar
manner
eukaryot
recombin
gene
express
variabl
surfac
protein
cellsurfac
protein
enzym
synthes
bacteri
cellsurfac
carbohydr
express
varieti
way
result
replic
slip
slippag
error
repair
simpl
tandem
nucleotid
repeat
involv
either
di
trior
tetranucleotid
neisseria
abl
take
incorpor
environment
dna
genom
effect
vaccin
neisseria
infect
yet
develop
neisseria
may
consid
extrem
exampl
howev
mani
bacteri
pathogen
like
streptococcu
mycoplasma
promot
antigen
variat
tend
util
one
techniqu
addit
report
dnarel
defect
much
greater
associ
bacteri
pathogen
symptomat
patient
sampl
bacteri
speci
isol
environment
sourc
pneumococcu
streptococcu
pneumonia
gramposit
cocci
bacteria
caus
otiti
media
bacteremia
pneumonia
public
health
concern
caus
morbid
mortal
adult
children
two
form
vaccin
polysaccharid
conjug
vaccin
current
market
prevent
pneumococc
infect
polysaccharid
vaccin
vaccin
adult
popul
conjug
vaccin
ad
immunogen
nonpneumococc
protein
conjug
pneumococc
polysaccharid
enhanc
immunogen
children
yet
known
vaccin
evok
complet
immun
infect
polysaccharid
capsul
major
virul
factor
bacteria
sever
capsul
type
identifi
form
basi
pathogen
antigen
serotyp
current
pneumococc
vaccin
combin
variou
capsular
polysaccharid
antigen
serotyp
common
particular
popul
current
differ
serotyp
known
cover
avail
vaccin
discoveri
common
antigen
produc
effect
vaccin
knowledg
genom
organ
differ
strain
led
possibl
advanc
drive
pneumococc
potenti
vaccin
search
differ
approach
consider
help
solv
lot
concern
current
vaccin
knowledg
mani
method
tri
determin
whether
sourc
effect
vaccin
design
accommod
serotyp
organ
search
antigen
common
serotyp
achiev
knowledg
genom
immunoinformat
introduct
genom
comput
technolog
given
new
direct
studi
bacteri
pathogenesi
vaccin
design
plasmodium
plasmodium
falciparum
undergo
two
life
cycl
one
human
mosquito
human
host
erythrocyt
hepatocyt
usual
display
modifi
parasit
protein
call
plasmodium
falciparum
erythrocyt
membran
protein
plasmodium
falciparum
hepatocyt
membran
protein
respect
protein
function
assist
parasit
evad
destruct
host
immun
system
protein
identifi
prime
ligand
respons
cytoadher
reset
caus
infect
rbc
host
tissu
sequest
thu
help
parasit
circumv
clearanc
host
spleen
membran
protein
also
shield
infect
host
cell
destruct
spleen
adher
endothelium
luckili
protein
express
long
come
attack
natur
acquir
immun
defenc
parasit
expand
var
gene
code
gene
exist
polymorph
famili
much
member
everi
genom
haploid
antigen
switch
work
well
member
polymorph
famili
also
call
antigenicvariantprotein
famili
interchang
express
protein
time
way
one
particular
protein
surfac
infect
rbc
express
given
time
studi
antigenicvariantprotein
famili
pertin
understand
group
singlefamili
result
meaning
antigen
activ
studi
tri
understand
languag
antigen
variant
protein
sought
know
protein
bind
properti
search
understand
correl
motif
infect
sever
vardb
databas
repositori
protein
sequenc
involv
antigen
variat
associ
function
antigen
variant
data
obtain
sever
pathogen
may
regroup
unifi
databas
enabl
research
sever
multicopi
gene
famili
access
compar
swiftli
singl
moment
updat
vardb
databas
contain
close
dna
sequenc
sever
protein
translat
ten
infecti
diseas
pathogen
gene
famili
novel
sequencingbas
approach
pacbio
differ
protein
sequenc
relat
sequenc
use
potenti
vaccin
target
trypanosoma
mani
pathogen
antigen
variabl
occur
infect
pathogenesi
enabl
escap
destruct
host
antibodi
instanc
eukaryot
parasit
take
genet
assort
rearrang
therebi
chang
surfac
antigen
readi
exampl
seen
trypanosoma
brucei
caus
organ
sleep
sick
trypanosoma
brucei
replic
bloodstream
outsid
cell
host
matur
cross
bloodbrain
barrier
caus
sever
fatal
complic
replic
bloodstream
parasit
subject
humor
well
cellular
immun
respons
evad
host
defens
encas
homogen
coat
glycoprotein
call
variant
surfac
glycoprotein
vsg
though
initi
invas
protein
coat
tend
protect
microb
immun
system
constant
exposur
coat
identifi
foreign
matter
point
immun
effector
launch
attack
particular
trypanosoma
brucei
divers
vsg
protein
code
thousand
gene
parasit
genom
unfortun
host
express
gene
mutual
exclus
express
vsg
gene
normal
due
genet
reassort
caus
new
allel
copi
site
express
trypanosom
abnorm
vsg
gene
evad
humor
immun
multipli
therebi
caus
reinfect
chronic
recur
infect
influenza
viral
infecti
diseas
due
infect
three
type
rna
virus
name
influenza
type
b
c
current
vaccin
contain
doubl
type
singl
type
b
strain
induc
strong
antibodi
respons
neuraminidas
surfac
glycoprotein
hemagglutinin
vaccin
howev
effect
protect
newli
emerg
virus
antigen
shift
drift
antigen
drift
result
chang
antigen
site
minor
chang
antigen
shift
result
new
viru
subtyp
hemagglutinin
neuraminidas
two
enzym
dictat
antigen
properti
virus
insid
host
defin
host
proteas
break
peptid
bond
hemagglutinin
molecul
form
hemagglutinin
subunit
virul
tendenc
decreas
amino
acid
cleavag
site
lipophob
viru
exhibit
high
virul
tendenc
surfac
glycoprotein
regard
antigen
henc
serv
target
immun
system
sequenc
use
new
immunoinformat
approach
common
site
vari
protein
identifi
potent
vaccin
develop
accommod
antigen
driftshift
viru
influenza
virus
abl
thrive
long
given
human
popul
viru
high
mutat
rate
effect
vaccin
easili
lose
efficaci
antigen
variabl
one
evid
phenotyp
variat
biolog
influenza
viru
use
immunoinformat
vaccin
develop
acceler
toward
design
multiepitop
vaccin
construct
fulli
address
challeng
face
pathogen
mutagen
antigen
previou
vaccin
develop
convent
approach
consist
sever
protein
whole
pathogen
constitut
unwarr
antigen
load
increas
chanc
induc
allergi
use
peptidebas
vaccin
surmount
challeng
vaccin
made
short
peptid
fragment
capabl
elicit
highli
specif
immun
respons
precis
target
multiepitop
construct
case
vari
antigen
peptid
made
feasibl
advanc
field
comput
biolog
vaccin
pathogen
immun
escap
potenti
basic
construct
use
immunogen
peptid
vaccin
prove
better
singleepitop
classic
vaccin
multiepitop
vaccin
enjoy
follow
advantag
singleepitop
classic
vaccin
assemblag
sever
epitop
obtain
distinct
protein
targetsantigen
intend
infect
b
multipl
tcell
receptor
tcr
vaccin
recipi
easili
recogn
vaccin
multipl
hla
epitop
c
easili
adjuv
improv
immunogen
activ
antibodymedi
cellmedi
immunolog
respons
overlap
helper
lymphocyt
htl
tcell
bcell
epitop
e
unwant
protein
antigen
exclud
construct
therebi
reduc
chanc
untoward
effect
immun
respons
like
caus
diseas
thu
produc
vaccin
qualiti
provid
chanc
combat
infect
streptococcu
pneumonia
hiv
infect
immunoinformat
employ
dock
singl
multiepitop
vaccin
subsequ
predict
properti
physicochem
allergen
antigen
approach
seen
use
divers
tool
databas
analysi
ligand
target
greatli
help
predict
bind
score
antigen
peptid
immun
protein
like
hla
peptid
hla
allel
model
done
structur
design
epitop
use
onlin
server
retriev
protein
data
bank
pdb
xray
crystallograph
structur
human
popul
occur
hla
allel
hlaa
follow
filtrat
previous
bound
ligand
follow
stepwis
detail
construct
singl
multiepitopebas
vaccin
properti
predict
molecular
dock
analysi
determin
interact
pattern
screen
epitop
hla
allel
employ
cluspro
proteinprotein
dock
web
server
server
perform
task
energi
minim
calcul
bind
energi
score
dock
complex
electrostaticshap
complementar
targetprotein
compar
model
associ
structur
valid
sequenc
amino
acid
target
protein
eg
retriev
uniprot
tertiari
structur
raptorx
tasser
onlin
compar
model
tool
server
construct
creat
model
immunotarget
therapi
mathemat
represent
target
protein
use
hierarch
algorithm
person
vaccin
refer
vaccin
target
toward
optim
outcom
immunogen
maxim
either
risk
vaccin
failur
reactogen
side
effect
minim
person
develop
follow
case
individu
level
vaccin
develop
take
care
haplotyp
polymorph
know
retard
format
protect
immun
respons
becom
pointer
risk
advers
vaccin
reaction
need
clear
femal
produc
higher
antibodi
titr
particular
vaccin
antigen
male
counterpart
clear
particular
human
race
ethnic
group
higher
lower
immun
respons
particular
vaccin
antigen
person
vaccin
aris
due
known
complex
interact
host
environment
genet
factor
may
influenc
vaccin
immun
respons
associ
immun
respons
gene
polymorph
variat
immun
respons
particular
gene
must
pinepoint
clear
particular
drug
either
suppress
augment
transcript
immun
respons
gene
could
help
design
vaccin
vaccin
adjuv
circumv
restrict
due
immunolog
differ
aris
vari
genet
composit
person
vaccin
stem
understand
within
human
leukocyt
antigen
hla
systemalso
refer
major
histocompat
complex
mhc
cell
abl
recogn
peptid
pathogen
origin
hla
molecul
enjoy
doubl
advantag
stabl
polymorph
fulli
character
advantag
make
good
candid
person
vaccin
design
hla
polymorph
although
stabl
complex
instanc
allel
hla
class
molecul
greater
class
ii
molecul
identifi
among
human
popul
hla
class
ii
molecul
heterodimer
charact
compris
chain
three
highli
variabl
extracellular
domain
transmembran
intracytoplasm
domain
less
variabl
hla
gene
contain
eight
exon
exon
respons
produc
leader
peptid
exon
produc
extracellular
domain
respect
mhc
class
respect
mhc
class
ii
exon
encod
transmembran
anchor
exon
encod
cytoplasm
tail
exon
encod
region
sever
form
associ
class
ii
gene
seen
known
class
known
class
ii
domain
mhc
ii
bind
present
peptid
cell
cell
respons
viral
pathogen
differ
one
patient
basic
express
differ
hla
mhc
allel
determin
sever
viral
amino
acid
sequenc
brought
cell
read
like
infect
divers
epitop
usual
present
cell
read
owe
sever
form
hla
allel
also
human
person
express
six
hla
class
six
hla
class
ii
allel
antibodybind
site
given
hla
mhc
molecul
mostli
predictionserv
predetermin
basi
particular
bind
motif
anchor
residu
residu
refer
known
amino
acid
locat
defin
locat
peptid
chain
peculiar
mhc
molecul
predictionserv
databas
peptid
motif
andor
mhc
ligand
may
obtain
webbas
andor
predictionserv
dedic
netmhc
famili
anoth
exampl
sequenc
analysi
lassa
fever
viru
lasv
virus
immunoproteom
use
identifi
best
immunogen
protein
predict
tcell
well
bcell
epitop
also
target
sequenc
bind
site
ssnlykgvi
peptid
sequenc
glycoprotein
produc
l
segment
best
candid
epitop
induct
humor
well
cellmedi
immun
lassa
fever
vaccin
construct
hlai
hlaii
molecul
proven
sizabl
african
popul
combin
ssnlykgvi
peptid
sequenc
may
prove
use
lassa
fever
viru
endem
area
approach
strongli
improv
individu
vaccin
help
combat
emerg
infect
hla
region
suspect
contribut
larg
extent
genet
propens
infect
differ
vaccin
expect
immun
respons
studi
show
femal
exhibit
stronger
immun
respons
immun
compar
male
differenti
antibodi
respons
rubella
measl
viral
protein
male
femal
hormon
genet
differ
may
influenc
immun
respons
practic
issu
may
stand
way
achiev
new
develop
person
vaccinolog
use
differ
vaccin
differ
person
base
person
genet
composit
requir
time
labor
vaccin
process
also
screen
individu
factor
target
vaccin
significantli
increas
vaccin
cost
challeng
person
vaccin
new
age
approach
achiev
optimum
immun
take
consider
individu
immun
differ
particular
popul
new
dawn
vaccin
develop
person
vaccin
develop
strongli
improv
vaccinom
field
vaccinom
look
immun
respons
gene
polymorph
affect
cellmedi
humor
innat
immun
respons
vaccin
antigen
popul
specif
individu
level
vaccinom
encompass
immunogenom
immunogenet
concern
immun
respons
vaccin
antigen
field
person
vaccinolog
vaccinom
product
phase
intern
hapmap
human
genom
project
also
modern
molecular
assay
techniqu
permit
highthroughput
detect
variat
gene
level
particular
linkag
disequilibrium
map
singl
nucleotid
polymorph
snp
play
signific
role
develop
person
vaccinolog
vaccinom
also
shown
polymorph
vital
immun
respons
gene
bring
differ
immun
respons
biopharmaceut
product
includ
vaccin
newer
accur
cheap
reproduc
sequenc
technolog
valid
databas
contain
genotypephenotyp
data
statist
bioinformat
tool
need
order
analyz
interpret
data
help
improv
vaccin
advers
immun
respons
quantifi
predict
inform
enhanc
clinic
practic
acceler
ration
direct
vaccin
develop
safe
vaccin
critic
requir
immun
program
convent
vaccin
approach
target
group
individu
fail
toward
enrol
pregnant
women
vaccin
program
presum
fetal
matern
harm
evid
safeti
vaccin
pregnanc
small
pregnant
women
usual
exclud
particip
vaccin
trial
pregnanc
alter
matern
well
fetal
immunolog
respons
pertin
explor
research
opportun
present
advanc
vaccin
design
immunoinformat
multiepitop
vaccin
dock
studi
human
immun
system
function
respons
specif
pregnant
women
unborn
children
accord
report
dominican
republ
congo
zika
viru
outbreak
thousand
pregnant
women
suspect
infect
viru
sizabl
number
first
trimest
report
state
fetal
loss
approxim
onetenth
pregnanc
case
fetu
head
circumfer
smaller
normal
widespread
morbid
epidem
show
zika
viru
infect
advers
affect
pregnanc
outcom
current
proof
pregnanc
predispos
ebola
viru
infect
comparison
nonpregn
popul
evid
suggest
pregnanc
worsen
diseas
prognosi
includ
fetal
loss
also
evid
show
viru
pass
placent
barrier
establish
infect
unborn
child
design
implement
enrol
pregnant
women
well
perspect
pregnant
women
vaccin
trial
program
imper
order
protect
group
ensur
good
vaccin
uptak
infect
outbreak
epidem
recommend
give
inform
decis
investig
use
immunoinformat
tool
determin
immunogen
respons
worthi
safe
vaccin
develop
pregnant
women
perspect
pregnant
women
group
matern
immun
offer
palpabl
benefit
sever
way
vaccin
primarili
administ
shield
pregnant
women
morbid
condit
death
includ
fetal
death
pregnant
women
stand
risk
expos
virul
pathogen
may
higher
risk
morbid
andor
mortal
compar
gener
popul
explos
new
immunolog
data
tabl
due
increas
research
understand
immun
system
pathway
infecti
diseas
pathogenesi
applic
knowledg
bioinformat
led
better
exposit
immun
system
import
immunoinformat
knowledg
immun
system
costeffect
specif
effect
approach
like
immunoinformat
concern
emerg
resurg
diseas
caus
pathogen
organ
antigen
variabilitycomplex
lifecycl
pathogen
need
person
vaccin
combat
molecular
level
futur
immunolog
research
sharpen
abil
make
discoveri
biolog
eg
vaccin
effect
effici
mean
reduct
better
target
wet
laboratori
experi
possibl
wet
laboratori
experiment
combin
bioinformat
techniqu
immunoinformat
depend
experiment
scienc
wet
laboratori
produc
raw
data
analysi
predict
formal
proof
concept
replac
tradit
experiment
research
method
actual
test
hypothes
qualiti
immunoinformat
predict
depend
qualiti
data
sophist
algorithm
use
sequenc
data
highthroughput
analysi
often
contain
error
sequenc
wrong
annot
incorrect
result
downstream
analysi
mislead
well
immunotarget
therapi
intern
peerreview
open
access
journal
focus
immunolog
basi
diseas
potenti
target
immun
base
therapi
treatment
protocol
employ
improv
patient
manag
basic
immunolog
physiolog
immun
system
health
diseas
also
cover
addit
journal
focu
impact
manag
program
new
therapeut
agent
protocol
patient
perspect
qualiti
life
adher
satisfact
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
immunotarget
therapi
